Matthew R Narlesky Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2022 Last refreshed 2026-03-16

unknown

3 h-index 6 pubs 60 cited

Biography and Research Information

OverviewAI-generated summary

Matthew R. Narlesky's research has focused on psychopharmacology and mental health interventions, with recent publications examining the use of psilocybin for psychiatric disorders and the management of attention deficits in Smith-Magenis syndrome. He has also investigated psychotropic treatment initiation in patients with specific medical conditions like Alpha-Gal syndrome and explored presentations of denial of pregnancy. Narlesky's work includes a systematic review on the safety profile of psilocybin in psychiatric treatment. His scholarship metrics include an h-index of 3, with 6 total publications and 60 total citations. He has collaborated with researchers at Harding University Main Campus, including Fahim Rasul, Suporn Braaten, and Robert G. Wooten, each sharing one publication.

Metrics

  • h-index: 3
  • Publications: 6
  • Citations: 60

Selected Publications

  • Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome (2022)
  • Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome (2022)
    1 citation DOI OpenAlex
  • Denial of Pregnancy in a Patient With a History of Pseudocyesis (2021)
    6 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

10 Collaborators 5 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics